Press release MHRA authorises diabetic issues drug Mounjaro (tirzepatide) for weight administration and weight loss For the first time in the united kingdom, obese people and people who are overweight with weight-relevant health problems could now have access to Mounjaro, at the moment useful for Kind 2 diabetic issues, to help control their weight